The observation of heightened EGFR expression in cancer cells, coupled with the established correlation between EGFR overexpression and reduced patient survival, has spurred the development of numerous therapeutic strategies aimed at specifically targeting EGFR. This evidence concerns the gene EGFR and cancer.